SCHEMBL3040934

SCHEMBL3040934

S=C1CC=CN=C1SSC1=NC=CCC1=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902126 0.84
SCHEMBL2402958 0.71
Bromide SCHEMBL11114085 0.70
SCHEMBL9525030 0.68
SCHEMBL10784568 0.68
SCHEMBL9297975 0.64
SCHEMBL2899010 0.61
SCHEMBL7849746 0.55
SCHEMBL12154070 0.55
SCHEMBL12601793 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12344687-B2 Synthetic polymers and crosslinked hydrogel systems MCMASTER UNIVERSITY (CA) 2025-07-01 US disclosed
US-20240150509-A1 Novel Synthetic Polymers and Crosslinked Hydrogel Systems MCMASTER UNIVERSITY (CA) 2024-05-09 US disclosed
US-11873358-B2 Synthetic polymers and crosslinked hydrogel systems MCMASTER UNIVERSITY (CA) 2024-01-16 US disclosed
US-20200148804-A1 Novel Synthetic Polymers and Crosslinked Hydrogel Systems MCMASTER UNIVERSITY (CA) 2020-05-14 US disclosed
EP-3630856-A1 NOVEL SYNTHETIC POLYMERS AND CROSSLINKED HYDROGEL SYSTEMS Mcmaster University (CA) 2020-04-08 EP disclosed
US-10391181-B2 Cyclodextrin and antibody-drug conjugate formulations SEATTLE GENETICS, INC. (US) 2019-08-27 US disclosed
US-20180369408-A1 CYCLODEXTRIN AND ANTIBODY-DRUG CONJUGATE FORMULATIONS SEATTLE GENETICS, INC. (US) 2018-12-27 US disclosed
WO-2018218346-A1 NOVEL SYNTHETIC POLYMERS AND CROSSLINKED HYDROGEL SYSTEMS MCMASTER UNIVERSITY (CA) 2018-12-06 WO disclosed
US-9987374-B2 Cyclodextrin and antibody-drug conjugate formulations SEATTLE GENETICS, INC. (US) 2018-06-05 US disclosed
US-20170232112-A1 CYCLODEXTRIN AND ANTIBODY-DRUG CONJUGATE FORMULATIONS SEATTLE GENETICS, INC. (US) 2017-08-17 US disclosed
EP-1874801-A2 INHIBITORS OF RECA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS The University of North Carolina at Chapel Hill (US) 2008-01-09 EP disclosed
WO-2006096757-A2 INHIBITORS OF RECA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2006-09-14 WO disclosed
US-20060199768-A1 Inhibitors of RecA activities for control of antibiotic-resistant bacterial pathogens UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2006-09-07 US disclosed
US-5429936-A Haptens, Claisen rearrangement THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1995-07-04 US disclosed
US-5314817-A Hapten modified with pyrimidine dimer or benzylammonium group, useful in reactions of proteins, nucleic acids and carbohydrates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1994-05-24 US disclosed
US-5302516-A Polypeptides having a binding site specific for a reactant and having an active functionality near that site to promote or catalyze the reaction; kinetics REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1994-04-12 US disclosed
US-5215889-A CATALYTIC AND REACTIVE POLYPEPTIDES AND METHODS FOR THEIR PREPARATION AND USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1993-06-01 US disclosed
EP-0445214-A4 CATALYTIC AND REACTIVE POLYPEPTIDES AND METHODS FOR THEIR PREPARATION AND USE 1991-11-13 EP disclosed
EP-0445214-A1 CATALYTIC AND REACTIVE ANTIBODIES AND ANTIBODY FRAGMENTS AND METHODS FOR THEIR PREPARATION AND USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1991-09-11 EP disclosed
WO-1990005746-A1 CATALYTIC AND REACTIVE POLYPEPTIDES AND METHODS FOR THEIR PREPARATION AND USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1990-05-31 WO disclosed